Correlation Between Qualigen Therapeutics and Rheinmetall

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Qualigen Therapeutics and Rheinmetall at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qualigen Therapeutics and Rheinmetall into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Qualigen Therapeutics and Rheinmetall AG ADR, you can compare the effects of market volatilities on Qualigen Therapeutics and Rheinmetall and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qualigen Therapeutics with a short position of Rheinmetall. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qualigen Therapeutics and Rheinmetall.

Diversification Opportunities for Qualigen Therapeutics and Rheinmetall

-0.46
  Correlation Coefficient

Very good diversification

The 3 months correlation between Qualigen and Rheinmetall is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Qualigen Therapeutics and Rheinmetall AG ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rheinmetall AG ADR and Qualigen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qualigen Therapeutics are associated (or correlated) with Rheinmetall. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rheinmetall AG ADR has no effect on the direction of Qualigen Therapeutics i.e., Qualigen Therapeutics and Rheinmetall go up and down completely randomly.

Pair Corralation between Qualigen Therapeutics and Rheinmetall

Given the investment horizon of 90 days Qualigen Therapeutics is expected to under-perform the Rheinmetall. In addition to that, Qualigen Therapeutics is 3.62 times more volatile than Rheinmetall AG ADR. It trades about -0.04 of its total potential returns per unit of risk. Rheinmetall AG ADR is currently generating about 0.12 per unit of volatility. If you would invest  4,073  in Rheinmetall AG ADR on September 2, 2024 and sell it today you would earn a total of  9,061  from holding Rheinmetall AG ADR or generate 222.47% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Qualigen Therapeutics  vs.  Rheinmetall AG ADR

 Performance 
       Timeline  
Qualigen Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Qualigen Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Rheinmetall AG ADR 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Rheinmetall AG ADR are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile fundamental drivers, Rheinmetall showed solid returns over the last few months and may actually be approaching a breakup point.

Qualigen Therapeutics and Rheinmetall Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Qualigen Therapeutics and Rheinmetall

The main advantage of trading using opposite Qualigen Therapeutics and Rheinmetall positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qualigen Therapeutics position performs unexpectedly, Rheinmetall can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rheinmetall will offset losses from the drop in Rheinmetall's long position.
The idea behind Qualigen Therapeutics and Rheinmetall AG ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities